Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Equities

Equities

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • Equities
  • Guidance
  • Movers
  • News

What’s Going On With Cognyte Software Shares After Q1 Results?

By Akanksha Bakshi
June 18, 11:27 AM
Cognyte Software reported Q1 results, beating revenue and EPS estimates. Gross margin and adjusted EBITDA improved, while cash and cash equivalents increased. FY 2025 outlook raised.

CGNT

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Intra-Cellular Therapies’ Highlights Successful Data From Second Depression Study

By Vandana Singh
June 18, 10:37 AM
Intra-Cellular Therapies reports positive topline results for Study 502 on lumateperone 42 mg as adjunctive therapy for major depressive disorder. FDA application expected in H2 2024.

ITCI

Read More
2 minute read
  • Contracts
  • Equities
  • General
  • Markets
  • Movers
  • News

What’s Going On With ChargePoint Shares Today?

By Nabaparna Bhattacharya
June 18, 10:26 AM
ChargePoint inked a new partnership with LG Electronics focusing on innovative EV charging solutions integrating ChargePoint's software with LG's advanced hardware.

CHPT

Read More
2 minute read
  • Earnings
  • Equities
  • General
  • Movers
  • News

Why America’s Car-Mart Shares Are Sliding Today

By Shivani Kumaresan
June 18, 10:18 AM
America's Car-Mart experienced a drop in shares following a fourth-quarter earnings shortfall, with EPS of $0.06 missing the expected $0.89.

CRMT

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Trading Ideas

Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical’s $1.3B Deal

By Vandana Singh
June 18, 10:02 AM
Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR system, a breakthrough in stroke prevention. Transaction closes in H2 2024.

BSX

Read More
1 minute read
  • Earnings
  • Equities
  • Financing
  • General
  • Movers
  • News

Why Is Telecommunications Firm Comtech Stock Surging On Tuesday?

By Shivani Kumaresan
June 18, 9:51 AM
Comtech Telecommunications sees a rise in shares after reporting Q3 results and securing a $222 million credit facility.

CMTL

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial

By Vandana Singh
June 18, 9:22 AM
AstraZeneca announced that the CAPItello-290 Phase 3 trial for Truqap (capivasertib) combined with paclitaxel in advanced or metastatic triple-negative breast cancer did not meet primary endpoints for overall survival.

AZN

Read More
1 minute read
  • Equities
  • General
  • Markets
  • Movers
  • News

What’s Going On With Trump Media & Technology Shares Today?

By Nabaparna Bhattacharya
June 18, 9:17 AM
Trump Media & Technology Group shares are down in premarket trading despite a recent surge, as the company addresses short selling concerns and plans expansion into streaming and media acquisitions.

DJT

Read More
2 minute read
  • Equities
  • General
  • Media
  • News

Amazon Labor Union Partners With Teamsters To Boost Bargaining Power: Report

By Shivani Kumaresan
June 18, 9:04 AM
In a landmark decision, 98% of Amazon Labor Union members voted to align with the International Brotherhood of Teamsters, aiming to boost their influence in negotiations for better employment conditions at Amazon.

AMZN

Read More
2 minute read
  • Equities
  • Markets
  • Media
  • News
  • Top Stories

Elon Musk Lures Tesla Employees With Stock Awards After His $56B Pay Package Receives Shareholder Backing: Report

By Shanthi Rexaline
June 18, 8:50 AM
Tesla is going all out to weather the fundamental challenges and a report suggests Musk & team is considering a strategy to keep employees motivated.

TSLA

Posts pagination

Previous 1 … 7 8 9 … 1,061 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service